Neurophysiology of Nicotine Addiction
- PMID: 22454789
- PMCID: PMC3312002
- DOI: 10.4172/2155-6105.S1-001
Neurophysiology of Nicotine Addiction
Abstract
Tobacco use is a major health problem, and nicotine is the main addictive component. Nicotine binds to nicotinic acetylcholine receptors (nAChR) to produce its initial effects. The nAChRs subtypes are composed of five subunits that can form in numerous combinations with varied functional and pharmacological characteristics. Diverse psychopharmacological effects contribute to the overall process of nicotine addiction, but two general neural systems are emerging as critical for the initiation and maintenance of tobacco use. Mesocorticolimbic circuitry that includes the dopaminergic pathway originating in the ventral tegmental area and projecting to the nucleus accumbens is recognized as vital for reinforcing behaviors during the initiation of nicotine addiction. In this neural system β2, α4, and α6 are the most important nAChR subunits underlying the rewarding aspects of nicotine and nicotine self-administration. On the other hand, the epithalamic habenular complex and the interpeduncular nucleus, which are connected via the fasciculus retroflexus, are critical contributors regulating nicotine dosing and withdrawal symptoms. In this case, the α5 and β4 nAChR subunits have critical roles in combination with other subunits. In both of these neural systems, particular nAChR subtypes have roles that contribute to the overall nicotine addiction process.
Conflict of interest statement
The authors are not aware of any affiliations, memberships, funding, financial holdings, or any other conflicts of interests that might be perceived as affecting the objectivity of this review.
Similar articles
-
Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction.Neuropharmacology. 2020 Oct 15;177:108256. doi: 10.1016/j.neuropharm.2020.108256. Epub 2020 Jul 29. Neuropharmacology. 2020. PMID: 32738308 Free PMC article. Review.
-
Reward, addiction, withdrawal to nicotine.Annu Rev Neurosci. 2011;34:105-30. doi: 10.1146/annurev-neuro-061010-113734. Annu Rev Neurosci. 2011. PMID: 21438686 Free PMC article. Review.
-
β4-Nicotinic Receptors Are Critically Involved in Reward-Related Behaviors and Self-Regulation of Nicotine Reinforcement.J Neurosci. 2020 Apr 22;40(17):3465-3477. doi: 10.1523/JNEUROSCI.0356-19.2020. Epub 2020 Mar 17. J Neurosci. 2020. PMID: 32184221 Free PMC article.
-
Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior.Biochem Pharmacol. 2011 Oct 15;82(8):984-95. doi: 10.1016/j.bcp.2011.06.026. Epub 2011 Jun 29. Biochem Pharmacol. 2011. PMID: 21740894 Free PMC article. Review.
-
Neurobiological Mechanisms of Nicotine Reward and Aversion.Pharmacol Rev. 2022 Jan;74(1):271-310. doi: 10.1124/pharmrev.121.000299. Pharmacol Rev. 2022. PMID: 35017179 Free PMC article. Review.
Cited by
-
Nicotinic acetylcholine receptor subunits α4 and α5 associated with smoking behaviour and lung cancer are regulated by upstream open reading frames.PLoS One. 2013 Jul 2;8(7):e66157. doi: 10.1371/journal.pone.0066157. Print 2013. PLoS One. 2013. PMID: 23843950 Free PMC article.
-
Molecular Mechanism: ERK Signaling, Drug Addiction, and Behavioral Effects.Prog Mol Biol Transl Sci. 2016;137:1-40. doi: 10.1016/bs.pmbts.2015.10.017. Epub 2015 Nov 17. Prog Mol Biol Transl Sci. 2016. PMID: 26809997 Free PMC article. Review.
-
Nicotine Acts on Cholinergic Signaling Mechanisms to Directly Modulate Choroid Plexus Function.eNeuro. 2019 Apr 23;6(2):ENEURO.0051-19.2019. doi: 10.1523/ENEURO.0051-19.2019. eCollection 2019 Mar-Apr. eNeuro. 2019. PMID: 31119189 Free PMC article.
-
Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo.J Neurochem. 2013 Oct;127(2):187-98. doi: 10.1111/jnc.12373. Epub 2013 Aug 20. J Neurochem. 2013. PMID: 23875705 Free PMC article.
-
Exenatide once weekly for smoking cessation: study protocol for a randomized clinical trial.Medicine (Baltimore). 2018 Jan;97(2):e9567. doi: 10.1097/MD.0000000000009567. Medicine (Baltimore). 2018. PMID: 29480848 Free PMC article. Clinical Trial.
References
-
- Peto R, Lopez AD, Boreham J, Thun M, Heath C, Jr, et al. Mortality from smoking worldwide. Br Med Bull. 1996;52:12–21. - PubMed
-
- Benowitz NL. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther. 2008;83:531–541. - PubMed
-
- WHO. Tobacco or health, a global status report. World Health Organization; 1997. p. 495.
-
- Corrigall WA. Nicotine self-administration in animals as a dependence model. Nicotine Tob Res. 1999;1:11–20. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources